Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau
It has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine
Canada will invest up to C$214 million ($162.8 million) to help develop a domestically made COVID-19 vaccine, and it has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine, Prime Minister Justin Trudeau said on Friday.
The government will also invest up to C$18.2 million in Vancouver-based biotechnology company Precision NanoSystems Incorporated (PNI) to support a project for pre-clinical and clinical trials for a vaccine.
(Edits by EP News Bureau)